[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f0KokFYfsEzCxa8dKKENOZsZenYQ18voQgbq3wRpizTU":8,"$fNKWAGogZQNRb0HTlGoxTwAn7w3DNuXZNw6Mem9Qj9c8":61,"$fJ1ZEv2Ag4DQx18OfhBewRrqmem3sTjwM-_ucO5IVghA":62,"$fYbjN3D19e4a8TvSyuZxZvQhbiMIMumzMhy0DmrRwzYQ":66},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":60},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"roleType":17,"adept":18,"hospital":19,"department":20,"postsTitle":21,"materialTotal":17,"videoTotal":22,"isConcern":7,"title":23,"coverVertical":24,"coverAcross":25,"directionMarker":26,"description":27,"vid":28,"time":29,"mediaType":30,"views":31,"likes":17,"isThumbsUp":7,"isCollection":7,"collections":17,"createTime":32,"seoTitle":33,"seoKeywords":34,"seoDescription":35,"shelvesTime":36,"menus":37,"menuId":39,"type":26,"quality":57,"commentCount":17,"isComment":30,"deviceType":58,"url":59},7305,865802,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//SQkfa7jIedfYA96phiKE0VEj62N2msft.png","晏金涛",0,"擅长对高血压、2型糖尿病、心脑血管疾病、耳鸣及耳聋有丰富的诊疗经验。","石家庄市新华区东焦街道办事处社区卫生服务中心","全科医疗","主治医师",8,"5大联合用药方案：瑞舒伐他汀+氨氯地平+脑心通如何协同降压降脂？","https://cdn.yishi-tong.com/console/3/G7mkrmNQvmasWF5haV2di4yzYHyIGtOt.png","https://cdn.yishi-tong.com/console/3/-Cjtf_mPlFtYsAxji2iCU2rsCoXvGpzK.png",2,"\u003Ch2>5大联合用药方案：瑞舒伐他汀+氨氯地平+脑心通如何协同降压降脂？\u003C/h2>\n\u003Cp>大家好，我是晏金涛，来自石家庄市新华区东焦街道办事处社区卫生服务中心的全科医生。今天我们来聊聊高血压和高脂血症的联合用药方案，特别是针对70岁女性患者刘智秀的案例。\u003C/p>\n\u003Cp>刘智秀女士的基本情况是：她身高163cm，体重51kg，长期受到高血压和高脂血症的困扰。经过详细的体格检查，发现她的精神状态良好，心肺功能正常，双下肢无水肿，生命体征稳定。她目前正在接受长期药物治疗，主要包括瑞舒伐他汀、脑心通和氨氯地平。\u003C/p>\n\u003Cp>首先，瑞舒伐他汀是一种常用的他汀类药物，主要用于降低血脂，尤其是低密度脂蛋白胆固醇（LDL-C）。对于高脂血症患者，瑞舒伐他汀能够有效降低心血管疾病的风险，改善患者的整体健康状况。\u003C/p>\n\u003Cp>其次，氨氯地平是一种钙通道阻滞剂，主要用于治疗高血压。它通过扩张血管，降低血压，从而减轻心脏负担。对于刘智秀这样的高血压患者，氨氯地平的使用能够帮助她维持稳定的血压水平，减少心血管事件的发生。\u003C/p>\n\u003Cp>最后，脑心通是一种中成药，主要用于改善脑部血液循环，增强心脏功能。它在高血压和高脂血症患者中，能够起到辅助治疗的作用，帮助改善患者的生活质量。\u003C/p>\n\u003Cp>这三种药物的联合使用，形成了一个有效的治疗方案。瑞舒伐他汀和氨氯地平分别针对血脂和血压，而脑心通则起到辅助作用，三者相辅相成，能够更好地控制患者的病情。\u003C/p>\n\u003Cp>需要注意的是，长期用药的患者应定期进行评估，监测药物的疗效和可能的不良反应。刘智秀目前的病情稳定，但我们仍需关注她的生活方式，鼓励她保持健康的饮食和适量的运动，以进一步提升生活质量。\u003C/p>\n\u003Cp>总之，针对高血压和高脂血症的联合用药方案，能够有效控制病情，降低心血管风险。希望通过今天的分享，大家对高血压和高脂血症的治疗有更深入的了解。\u003C/p>\n","v0247cg10004d2v8j6iljht2sbvqtdp0",181,1,416,"2025-06-24 09:57:34"," 瑞舒伐他汀+氨氯地平+脑心通联合用药方案：协同降压降脂的5大优势解析  "," 瑞舒伐他汀,氨氯地平,脑心通,联合用药,降压降脂,心血管疾病,协同作用,他汀类药物,钙拮抗剂,中成药  "," 本文深入解析瑞舒伐他汀、氨氯地平与脑心通胶囊的联合用药方案，从机制协同、疗效互补等5大维度阐述其降压降脂优势，帮助患者理解多药联用对心脑血管疾病的综合保护作用。","2025-06-30 17:07:36",[38],{"menuId":39,"menuName":40,"parentId":17,"orderNum":41,"path":42,"component":43,"isFrame":44,"isCache":45,"menuType":46,"visible":30,"status":17,"createDept":6,"remark":47,"createTime":48,"children":49,"columnImage":50,"columnLogo":51,"uncheckedLogo":6,"checkedLogo":6,"isHot":17,"isHome":17,"forceLogin":17,"color":6,"seoTitle":52,"seoKeywords":53,"seoDescription":54,"contentNum":6,"promotionalPoster":55,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":56,"routerPath":42,"componentInfo":43},"1986622624134549505","科普视频",3,"video","/video.html","1","0","T","","2025-11-07 10:31:58",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:40/0d7fcb56-3dc4-4dcb-99ca-a5d5c438378e.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:43/958efac7-dd02-4681-b8fd-0dd84b1bbf42.png","健康科普视频大全,了解你的健康生活","健康科普视频, 戒烟视频, 饮食健康视频, 胸痛科普, 用药知识, 职业健康视频, 贫血科普, 眼健康视频","精选健康科普视频,涵盖戒烟、胸痛、饮食、用药与职业健康等多个主题,让你轻松获取科学健康知识,提升生活质量。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:45/fa8fe113-deaa-4454-8105-d629769963dd.png","Video","慢性病",4,"https://vod.haohuanjiao.com/huanjiao/specialistVideo/865802/a76bc187-87d7-4490-9b99-33c3c795425c.tmp?a=0&auth_key=1789006823-434a418733734b8d9c7430b21a00bf46-0-14f548c0a7fd7c5dfc729e7abcb43721&br=668&bt=668&cd=0%7C0%7C0&ch=0&cr=0&cs=0&dr=0&ds=3&eid=v0247cg10004d2v8j6iljht2sbvqtdp0&er=0&l=20260811001716451D9A0B94A77F775DB6&lr=&mime_type=video_mp4&net=0&pl=0&qs=13&rc=M2d0ZTVrbzk7NTczNGY3M0Apc3d5dndtbG15ZzMzajo1eWdtcXNwcWdmZ3NhLS1kNC9zcy1hbl8vZWkzNS8xLS5gMS06Yw%3D%3D&vl=&vr=",true,{"code":9,"msg":59,"message":6,"data":6,"success":60},{"code":9,"msg":10,"message":6,"data":63,"success":60},{"pageNo":30,"pageSize":64,"result":65,"totalSize":17},10,[],{"code":9,"msg":10,"message":6,"data":67,"success":60},{"authors":68,"appraiseDimensionScoresVos":69},[],[]]